Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s stock price traded up 1% on Monday . The company traded as high as $0.50 and last traded at $0.5250. 1,683 shares were traded during trading, a decline of 22% from the average daily volume of 2,164 shares. The stock had previously closed at $0.52.
Nutriband Stock Up 1.0%
The firm’s fifty day simple moving average is $1.03 and its 200-day simple moving average is $1.28.
Institutional Investors Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new position in Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises 0.1% of Empery Asset Management LP’s portfolio, making the stock its 20th largest position.
About Nutriband
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
See Also
- Five stocks we like better than Nutriband
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
- A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
- Why Gold Miners Could Be the Market’s Biggest Comeback Story
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
